Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_6035_Библиотеки_им_академика_М_И_Перельмана.pdf
X
- •About the Editor
- •Contents
- •Contributors
- •Abbreviations
- •Preface
- •1. Natural Products as Drug Candidates
- •1.1 Introduction
- •1.2 An array of natural products
- •1.2.1 Plant-derived natural products
- •1.2.2 Microbial natural products
- •1.3 Importance of analytical techniques
- •1.3.1 A glance at extraction techniques
- •1.3.2 Microbial culturing techniques
- •1.3.3 Outlook and perspectives in nanoparticles
- •1.4 Natural products as a guide in drug design and synthesis
- •1.5 Natural products as promising drug candidates
- •1.5.1 Antiviral drug candidates
- •1.5.2 Antiparasitic drug candidates
- •1.5.3 Neuroprotective agents
- •1.6 Conclusion
- •Keywords
- •References
- •2. Traditional Knowledge for Drug Discovery
- •2.1 Introduction
- •2.2 Databases on indian remedial flora, indigenous medicines, and phytochemicals
- •2.2.1 Cultural preservation
- •2.2.2 Sustainable practices
- •2.2.3 Biodiversity conservation
- •2.2.4 Health and medicine
- •2.2.5 Climate change adaptation
- •2.2.6 Interconnectedness and wisdom
- •2.3 History of traditional knowledge
- •2.3.1 Indigenous healing practices
- •2.3.2 Aboriginal dreamtime
- •2.3.3 Traditional agriculture
- •2.3.4 Traditional crafts
- •2.3.5 Indigenous cosmologies
- •2.3.6 Traditional music and dance
- •2.3.7 Traditional navigation
- •2.4 Traditional medicine in plant formulations
- •2.4.1 Ayurveda
- •2.4.2 Traditional chinese medicine
- •2.4.3 Indigenous healing practices
- •2.5 Drug discovery
- •2.6 Aspects of developing plant-based drugs
- •2.6.1 Selection criteria for plants
- •2.6.2 Plant material authentication
- •2.6.3 Extraction methods
- •2.6.4 Isolation and structure elucidation of bioactive components
- •2.6.5 Standardization of plant formulations
- •2.7 Conclusions
- •References
- •3. Herbal Healing: Plant-Based Natural Products
- •3.1 Introduction
- •3.2 Classification of secondary metabolites
- •3.2.1 Phenolic compounds
- •3.2.2 Terpenes
- •3.2.3 Alkaloids
- •3.3 History of natural products
- •3.4 Drug discovery from natural products
- •3.5 Drugs derived from the plants
- •3.6 Conclusions
- •Keywords
- •References
- •4. Natural Products with Antimicrobial Properties
- •4.1 Introduction
- •4.2 Plants as antimicrobial agents
- •4.3 Marine sources as antimicrobial agents
- •4.4 Antimicrobial products derived from microorganisms
- •4.5 Conclusions and future trends
- •Keywords
- •References
- •5. Natural Products with Immunomodulatory Properties
- •5.1 Introduction
- •5.2.1 Aloe vera (l.) burm.f. (family: asphodelaceae)
- •5.2.2 Andrographis paniculata (burm. f.) wall.ex.nees. (family: acanthaceae)
- •5.2.3 Acorus calamus l. (family: araceae)
- •5.2.4 Allium sativum l. (family: alliaceae)
- •5.2.5 Azadirachta indica a. juss. (family: meliaceae)
- •5.2.6 Argyreia speciosa (l.f.) sweet (family: convolvulaceae)
- •5.2.7 Bidens pilosa l. (family: asteraceae)
- •5.2.8 Baliospermum montanum (willd.) müll.arg. (family: euphorbiaceae)
- •5.2.9 Boerhaavia diffusa l. (family: nyctaginaceae)
- •5.2.10 Boswellia serrata roxb. excolebr. (family: burseraceae)
- •5.2.11 Camellia sinensis (l.) kuntze (family: theaaceae)
- •5.2.12 Capparis zeylanica l. (family: capparidaceae)
- •5.2.13 Calendula officinalis l. (family: asteraceae)
- •5.2.14 Chelidonium majus l. (family: papaveraceae)
- •5.2.15 Carica papaya l. (family: caricaceae)
- •5.2.26 Glycyrrhiza glabra l. (family: leguminosae)
- •5.2.27 Hypericum perforatum l. (family: hypericaceae)
- •5.2.28 Hippophae rhamnoides l. (family: elaeagnaceae)
- •5.2.29 Hydrastis canadensis l. (family: ranunculaceae)
- •5.2.30 Jatropha curcas l. (family: euphorbiaceae)
- •5.2.31 Mangifera indica l. (family: anacardiaceae)
- •5.2.32 Mollugo verticillata l. (family: molluginaceae)
- •5.2.33 Matricaria chamomilla l. (family: asteraceae)
- •5.2.34 Momordica charantia l. (family: cucurbitaceae)
- •5.2.35 Morinda citrifolia l. (family: rubiaceae)
- •5.2.36 Nigella sativa l. (family: ranunculaceae)
- •5.2.37 Nelumbo nucifera gaertn. (family: nymphaeceae)
- •5.2.38 Nerium oleander l. (family: apocynaceae)
- •5.2.39 Ocimum tenuiflorum l. (family: labiatae)
- •5.2.40 Premna tomentosa willd. (family: verbanaceae)
- •5.2.41 Plantago sp. (plantago major l. and plantago asiatica l.) (family: plantaginaceae)
- •5.2.42 Psoralea corylifolia l. (family: fabaceae)
- •5.2.43 Prunella vulgaris l. (family: lamiaceae)
- •5.2.44 Punica granatum l. (family: punicaceae)
- •5.2.45 Rhinacanthus nasutus (l.) kurz (family: acanthaceae)
- •5.2.46 Salvia officinalis l. (family: lamiaceae)
- •5.2.47 Tamarindus indica l. (family: leguminosae)
- •5.2.48 Tinospora cordifolia (willd.) miers (family: menispermaceae)
- •5.2.16 Centella asiatica (l.) urb. (family: umbelliferae)
- •5.2.17 Cichorium intybus l. (family: asteraceae)
- •5.2.18 Cryptolepis dubia (burm.f.) m.r. almeida (family: apocynaceae)
- •5.2.19 Citrus aurantiifolia (christm.) swingle (family: rutaceae)
- •5.2.20 Curcuma longa l. (family: zingiberaceae)
- •5.2.21 Desmodium gangeticum (l.) dc. (family: fabaceae)
- •5.2.22 Eclipta prostrata (l.) (family: asteraceae)
- •5.2.23 Phyllanthus emblica l. (family: euphorbiaceae)
- •5.2.24 Evolvulus alsinoides (l.) (family: convolvulaceae)
- •5.2.25 Ficus benghalensis l. (family: moraceae)
- •5.2.49 Terminalia chebula retz. (family: combretaceae)
- •5.2.51 Urtica dioica l. (family: urticaceae)
- •5.2.52 Withania somnifera (l.) dunal (cultivated var.) (family: solanaceae)
- •5.3 Traditional importance of research to society and researchers
- •5.4 Conclusion
- •Keywords
- •References
- •6. Natural Products with Anticancerous Properties
- •6.1 Introduction
- •6.2 Plant-derived anticancer compounds
- •6.2.1 Polyphenols
- •6.2.2 Flavanoids
- •6.2.3 Brassinosteroids
- •6.2.4 Vinca alkaloids
- •6.2.5 Taxanes
- •6.2.6 Campothecin derivatives
- •6.3 Microorganisms-based anticancer compounds
- •6.3.1 Primary metabolites
- •6.3.2 Secondary metabolites
- •6.4 Selected medicinal plants with anticancerous activities
- •6.4.1 Curcuma longa l.
- •6.4.2 Viscum album l.
- •6.4.3 Colchicum autumnale l.
- •6.4.4 Raphanus sativus l.
- •6.4.5 Tinospora cordifolia wild
- •6.4.6 Nigella sativa l.
- •6.5 Therapeutic enzymes
- •6.6 Future perspective
- •6.7 Conclusion
- •Keywords
- •References
- •7. Natural Products with Antiviral Properties
- •7.1 Introduction
- •7.2 Source of natural products with antiviral activity
- •7.3 Main components of natural products
- •7.3.1 Flavonoids
- •7.3.2 Polyphenols
- •7.3.3 Polysaccharides
- •7.3.4 Terpenoids
- •7.4 Mechanisms of action of natural compounds in viral infections
- •7.4.1 Direct antiviral effect
- •7.4.2 Anti-inflammatory effect in viral infections
- •7.4.3 Effect on autophagy process
- •7.6 Conclusions
- •Keywords
- •References
- •8. Approaches to Develop Drugs from Natural Products
- •8.1 Introduction
- •8.2 Scenario of drug discovery
- •8.3 Efficient drug discovery engines
- •8.4 Drug discovery approaches using plants
- •8.4.1 Plant selection for screening purpose
- •8.4.2 Authentication of plants
- •8.4.3 Types of molecular markers
- •8.5.1 Parallel approach
- •8.5.2 Sequential approach
- •8.6 Structure elucidation of isolated compounds
- •8.7 Biological screening of extracts/fraction/isolates
- •8.7.1 Cell culture-based assay
- •8.7.2 Dialysis
- •8.7.3 Microdialysis
- •8.7.4 Ultrafiltration
- •8.7.5 Chromatography
- •8.7.6 Ligand fishing
- •8.8 Limitations
- •8.9 Molecular modelling and np database
- •8.10 Future thrust
- •8.11 Conclusion
- •Keywords
- •References
- •9. Strategies for Isolation and Identification of Bioactive Molecules from Natural Sources
- •9.1 Introduction
- •9.2 Bioactive compounds in natural sources and their pharmacological properties
- •9.3.1 Selection of materials
- •9.3.3 Types and properties of solvent for extraction
- •9.4 Extraction methods (conventional and modern)
- •9.4.1 Conventional methods
- •9.4.2 Novel extraction methods
- •9.5 Concentration and purification of bioactive molecules using chromatographic techniques
- •9.5.1 Separation based on adsorption properties
- •9.5.2 Separation based on partition coefficient
- •9.5.3 Separation based on the molecular size
- •9.5.4 Separation based on ionic strength
- •9.5.5 Other modern separation techniques
- •9.6 Identification and characterization of bioactive molecules
- •9.6.1 Qualitative and quantitative techniques/chromatographic or nonchromatographic techniques
- •9.7 Conclusions
- •Keywords
- •References
- •10. Role of Omics in Natural Product-Based Drug Discovery
- •10.1 Introduction
- •10.2 Genomics and transcriptomics in natural product discovery
- •10.2.1 Case studies and examples of natural product discovery using genomics and transcriptomics
- •10.2.2 Limitations and challenges of using genomics and transcriptomics in natural product discovery
- •10.3 Proteomics and metabolomics in natural product discovery
- •10.3.1 Case studies and examples of natural product discovery using proteomics and metabolomics
- •10.4 Bioinformatics in natural product-based drug discovery
- •10.4.1 Role of bioinformatics in natural product-based drug discovery
- •10.4.2 The use of bioinformatics to predict and annotate natural product biosynthetic pathways, gene clusters, and metabolomics
- •10.7 Future perspectives and potential impact of omics in natural product-based drug discovery
- •10.9 Potential impact on drug discovery and development
- •10.10 Conclusion
- •Keywords
- •References
- •11. Natural Products from Endophytic Microorganisms
- •11.1 Introduction
- •11.1.1 Rational/why endophytes?
- •11.2 Diversity of endophytic microorganisms
- •11.2.1 Endophytic bacteria and endophytic actinomycetes
- •11.2.2 Endophytic fungi
- •11.3.1 ISolation methods
- •11.3.1.1.1 Dilution Plating
- •11.3.1.1.2 Direct Plating
- •11.3.2 Identification methods
- •11.4 Bioactive compounds from endophytic microorganisms
- •11.4.1 Antibiotics
- •11.4.2 Antifungal agents
- •11.4.3 Antimalarial agents
- •11.4.4 Antiviral agents
- •11.4.5 Anticancer agents
- •11.4.6 Antioxidants
- •11.5 Stepwise methods for natural product discovery from endophytic microorganisms
- •11.5.1 Plant selection rationale
- •11.5.2 Isolation and cultivation of endophytes
- •11.5.3 Characterization of endophytes
- •11.5.4 Extraction of natural products
- •11.5.5 Purification of natural products
- •11.6 Biosynthesis and strategies for the optimization of natural product discovery from endophytic microorganisms
- •11.6.1 Exploration of novel microbial sources
- •11.6.2 Metabolomics-guided discovery
- •11.6.3 Coculture
- •11.6.4 Genome mining
- •11.6.5 Modulation by ultraviolent irradiation
- •11.7 Future directions and challenges
- •11.7.1 Improving the efficiency and accuracy of screening methods
- •11.7.2 Enhancing the scalability and affordability of production methods
- •11.7.3 Ensure natural product safety and efficacy
- •11.8 Conclusions
- •References
- •12. Natural Products with Antidiabetic Properties
- •12.1 Introduction
- •12.2 Natural products that regulate glucose absorption
- •12.2.1 Serotonin-derived products
- •12.2.2 Butyl-isobutyl-phthalate from laminaria japonica
- •12.2.3 Bioactive compounds of allium cepa and allium sativum
- •12.2.4 Elatosides E and F of aralia elata
- •12.2.5 Bioactive compounds of bauhinia candicans and bauhinia forficate
- •12.3 Natural products that enhance insulin sensitivity
- •12.3.1 Astragalus membranaceus polysaccharides
- •12.3.2 Bioactive compounds of litchi chinensis
- •12.3.3 Bioactive compounds of fenugreek
- •12.3.4 Bioactive compounds of cinnamon
- •12.3.5 Bioactive compounds of gastrodia elata
- •12.3.6 Polysaccharides of dioscorea
- •12.3.7 Anthocyanins of blueberries
- •12.3.8 Bioactive compounds of psidium guajava
- •12.4.1 Gingerol from zingiber officinale
- •12.4.2 Curcumin from curcuma longa
- •12.4.3 Berberine
- •12.4.4 Capsaicin of pepper
- •12.4.5 Bioactive compounds of bitter melon
- •12.4.6 Ginsenosides of ginseng
- •12.4.7 Bioactive compounds of aloe vera
- •12.4.8 Quinides of coffee
- •12.4.9 Bioactive compounds of tinospora cordifolia
- •12.4.10 Bioactive compounds of pterocarpus marsupium
- •12.4.11 Eugenol of ocimum sanctum
- •12.4.12 Bioactive compounds of syzygium densiflorum
- •12.5 Clinical trials based on antidiabetic effects of natural products derived from plants
- •12.5.1 Gymnema sylvestre (gurmar)
- •12.5.2 Fenugreek (trigonella foenum-graecum)
- •12.5.3 Tea catechins
- •12.5.4 Coffee
- •12.5.5 Rosemary (rosmarinus officinalis)
- •12.6 Conclusion
- •12.7 Future scope
- •Keywords
- •References
- •13. Marine-Derived Natural Products with Anticancer Properties
- •13.1 Introduction
- •13.2 Marine bioactive compounds
- •13.3 Anticancer activity of marine plants
- •13.4 Anticancer agents from marine floras
- •13.5.1 Antioxidants
- •13.5.2 Immunomodulation and apoptosis
- •13.5.3 Nutritional values and anticancer effects
- •13.6 Nature and cancer chemotherapy
- •13.7 Marine organisms and cancer chemotherapy
- •13.8 Anticancer agents from marine floras
- •13.9 Marine plants
- •13.9.1 Macro algae (seaweed)
- •13.9.2 Mangroves and other higher plants
- •13.9.3 Cyanobacteria
- •13.9.4 Bacteria
- •13.9.5 Proteobacteria
- •13.9.6 Cyanobacteria
- •13.9.7 Actinomycetes
- •13.9.8 Marine fungi
- •13.9.9 Soft corals
- •13.9.10 Marine sponges
- •13.10 Anticancer bioactive antibiotics derived from marine sources
- •13.10.1 Polyphenols
- •13.10.2 Polysaccharides
- •13.10.3 Alkaloids
- •13.11 Other marine sources for anticancer compounds
- •13.11.1 Peptides
- •13.11.2 Plitidepsin
- •13.11.3 Trabectedin
- •13.11.4 Lurbinectedin
- •13.12 Marine natural products as anticancer drugs
- •13.13.1 Aquaculture/cultivation
- •13.13.2 Genetic engineering
- •13.13.3 Synthesis/semisynthesis/modification
- •13.14 Conclusions and future prospects
- •References
- •14. Natural Products as Novel Opportunities for Cathepsin Inhibitors
- •14.1 Introduction
- •14.2 Cysteine proteases (CPs)
- •14.2.1 Cathepsin
- •14.2.2 Structure and mechanism of action of cathepsins
- •14.3 NPs as cathepsins inhibitors
- •14.3.1 NPs From bacteria as cathepsin inhibitors
- •14.3.2 NPs from fungus as cathepsin inhibitors
- •14.3.3 NPs from marine organism as cathepsin inhibitors
- •14.3.4 NPs from plants as cathepsin inhibitors
- •14.4 Conclusion and future pespectives
- •Keywords
- •References
- •15. Phytoestrogens in Drug Discovery: A Focus on Mechanisms of Action and Safety Assessment
- •15.1 Introduction
- •15.2 Phytoestrogens and estrogen receptors
- •15.3 Nonestrogen receptor-mediated effects of phytoestrogens
- •15.3.1 Mitogen-activated protein kinase (MAPK) pathway
- •15.3.2 PI3K/AKT pathway
- •15.3.3 WNT pathway
- •15.3.4 G-protein-coupled estrogen receptor (GPER)
- •15.4 Structure–activity relationship (SAR) of phytoestrogens
- •15.4.1 Isoflavones
- •15.4.2 Lignans
- •15.4.3 Coumestans
- •15.4.4 Stilbenes
- •15.4.5 Diarylheptanoids
- •15.5 Comparing potency and efficacy of phytoestrogens on various pathways
- •15.5.1 Potency and efficacy of phytoestrogens on different pathways
- •15.5.2 Possible synergistic effects of phytoestrogens with other drugs
- •15.6 Effects of phytoestrogens on the human organs
- •15.7 Safety Assessment of phytoestrogens
- •15.7.1 Toxicity assays used to evaluate the safety of phytoestrogens
- •15.7.2 Potential adverse effects of phytoestrogens
- •15.8 Case study
- •15.8.1 Vaginal cellular differentiation assay
- •15.8.2 Changes in rat body weight
- •15.8.3 Changes in rats’ uterus weight
- •15.9 Current trends in phytoestrogen research
- •15.9.1 Publication trends
- •15.9.2 Analysis of contributing countries and contributing institutions
- •15.9.3 Analysis of contributing publishers and journals
- •15.9.4 Publication evolution and research areas
- •15.9.5 Limitations
- •15.10 Future directions
- •15.10.1 Exploration of unexplored plant sources
- •15.10.2 Understanding mechanisms of action
- •15.10.3 Synthesis of novel compounds
- •15.10.4 Development of SPERMs
- •15.10.5 Safety assessment
- •15.11 Conclusion
- •Keywords
- •References
- •16. Honey Bee Products with Antimicrobial Properties
- •16.1 Introduction
- •16.2 Honey
- •16.3 Bee bread (perga)
- •16.4 Bee pollen
- •16.5 Bee propolis
- •16.6 Conclusion
- •Keywords
- •References
- •17. Natural Products for the Prevention of Leaky Gut
- •17.1 Introduction
- •17.2 The physical and chemical barriers of the intestine
- •17.2.1 Thick mucus layer
- •17.2.2 Intestinal epithelial cells (IECS)
- •17.2.3 Intestinal junctional complexes
- •17.2.4 Lamina propria
- •17.2.5 Intestinal regulatory T cells
- •17.2.6 Intestinal alkaline phosphatase
- •17.2.7 Antimicrobial peptides
- •17.2.8 Lysozyme
- •17.3 Mechanistic view of factors leading to a leaky gut
- •17.3.1 Gut dysbiosis
- •17.3.2 Mucosal inflammation and oxidative stress
- •17.3.3 TJ disruption
- •17.3.4 Genetics
- •17.3.5 Drugs
- •17.4 Pathological implications of a leaky gut
- •17.5 Natural product improving gut microbial dysbiosis
- •17.5.1 Traditional herbs and polyherbal formulations managing gut micro flora
- •17.5.2 Phytocompounds in the management of intestinal barrier integrity through balancing gut microflora
- •17.6.1 Anti-inflammatory traditional medicine and plant extracts ameliorating intestinal mucosal injury
- •17.6.2 Plant active constituents preventing mucosal injury and oxidative damage
- •17.7 Traditional medicine and natural products upregulating the TJ proteins
- •17.7.1 Traditional medicine and herbal extracts promoting junction protein protection
- •17.7.2 Phytocompounds for junction protein protection
- •17.8 Natural products averting pathological conditions through maintaining intestinal barrier function
- •17.9 Conclusion
- •Keywords
- •References
- •18. Role of Natural Products in the Pharmacotherapy of Osteoporosis
- •18.1 Introduction
- •18.1.1 Effect of traditional chinese medicine (TCM)
- •18.1.2 Effect of malay traditional medicine
- •18.1.3 Antiosteoporotic agents extracted from plant sources
- •18.1.4 Treatment by different pigments
- •18.1.5 Other herbal sources
- •18.1.6 Natural plant-based alkaloids
- •18.1.7 Essential markers involved in bone formation and resorption for osteoporosis treatment
- •18.2 Conclusion
- •Keywords
- •References
- •19. Gel-Based Natural Therapeutics: Potential Alternatives to Traditional Drug Delivery Systems in Aquaculture
- •19.1 INtroduction
- •19.2 DDS
- •19.2.1 Water medication
- •19.3 Oral administration
- •19.3.1 Gavage

233
Rai, A.; Saito, K.; Yamazaki, M. Integrated omics analysis of specialized metabolism in medicinal plants. Plant
Mol. Biol. 2017, 90(4), 764–787.
Rochfort, S. Metabolomics reviewed: A new “omics” platform technology for systems biology and implications
for natural products research. J. Nat. Prod. 2005, 68(12), 1813–1820
Rodrigues, T .; Reker , D.; Schneider , P.; Schneider, G. Counting on natural products for drug design. Nat. Chem.
2016, 8(6), 531–541
Sachse, C.; Krausz, E.; Krönke, A.; Hannus, M.; Walsh, A.; Grabner, A.; Ovcharenko, D.; Dorris, D.; Trudel,
C.; Sönnichsen, B.; Echeverri, C. J. High-throughput RNA interference strategies for target discovery and
validation by using synthetic short interfering RNAs: Functional genomics investigations of biological
pathways. Meth. Enzymol. 2005, 392, 242–277.
Saldívar-González, F. I.; Aldas-Bulos, V. D.; Medina-Franco, J. L.; Plisson, F. Natural product drug discovery
in the artificial intelligence era. Chem. Sci. 2021, 13(6), 1526–1546.
Singh, K. S.; van der Hooft, J. J. J.; van Wees, S. C. M.; Medema, M. H. Integrative omics approaches for
biosynthetic pathway discovery in plants. Nat. Prod. Rep. 2022, 39(9), 1876.
Skinnider, M. A.; Johnston, C. W.; Gunabalasingam, M.; Merwin, N. J.; Kieliszek, A. M.; MacLellan, R. J.; Li,
H.; Ranieri, M. R. M.; Webster, A. L. H.; Cao, M. P. T.; Pfeifle, A.; Spencer, N.; To, Q. H.; Wallace, D. P.;
Dejong, C. A.; Magarvey, N. A. Comprehensive prediction of secondary metabolite structure and biological
activity from microbial genome sequences. Nat. Commun. 2020, 11(1), 6058.
Spraker, J. E.; Luu, G. T.; Sanchez, L. M. Imaging mass spectrometry for natural products discovery: A review
of ionization methods. Nat. Prod. Rep. 2020, 37(2), 150–162.
Takase, S.; Kurokawa, R.; Arai, D.; Kanto, K. K.; Okino, T.; Nakao, Y.; Kushiro, T.; Yoshida, M.; Matsumoto, K.
A quantitative shRNA screen identifies ATP1A1 as a gene that regulates cytotoxicity by aurilide B. Scientific
Rep. 2017, 7(1), 2002.
Thomford, N. E.; Senthebane, D. A.; Rowe, A.; Munro, D.; Seele, P.; Maroyi, A.; Dzobo, K. Natural products for
drug discovery in the 21st century: Innovations for novel drug discovery. Int. J. Mol. Sci. 2018, 19(6), 1578.
Tsakou, F.; Jersie-Christensen, R.; Jenssen, H.; Mojsoska, B. The role of proteomics in bacterial response to
antibiotics. Pharmaceuticals. 2020, 13(9), 1–27.
Walker, A. S.; Clardy, J. A machine learning bioinformatics method to predict biological activity from
biosynthetic gene clusters. J. Chem. Inf. Model. 2021, 61(6), 2560–2571.
Wang, M.; Carver, J. J.; Phelan, V. V.; Sanchez, L. M.; Garg, N.; Peng, Y.; Nguyen, D. D.; Watrous, J.; Kapono,
C. A.; Luzzatto-Knaan, T.; Porto, C.; Bouslimani, A.; Melnik, A. V.; Meehan, M. J.; Liu, W. T.; Crüsemann,
M.; Boudreau, P. D.; Esquenazi, E.; Sandoval-Calderón, M.; Bandeira, N. Sharing and community curation of
mass spectrometry data with global natural products social molecular networking. Nat. Biotech. 2016, 34(8),
828–837
Wang, Y.; Yu, R. Y.; He, Q. Y. Proteomic analysis of anticancer TCMs targeted at mitochondria. ECAM. 2015,
2015, 539260.
Winter, G.; Krömer, J. O. Fluxomics—connecting ’omics analysis and phenotypes. Environ. Microbiol. 2013,
15(7), 1901–1916.
Wishart, D. S. Emerging applications of metabolomics in drug discovery and precision medicine. Nat. Rev.
Drug Discov. 2016, 15(7), 473–484.
Wright, M. H.; Sieber, S. A. Chemical proteomics approaches for identifying the cellular targets of natural
products. Nat. Prod. Rep. 2016, 33(5), 681–708.
Wu, D.; Wang, W .; Chen, W.; Lian, F.; Lang, L.; Huang, Y.; Xu, Y.; Zhang, N.; Chen, Y.; Liu, M.; Nussinov, R.;
Cheng, F .; Lu, W.; Huang, J. Pharmacological inhibition of dihydroorotate dehydrogenase induces apoptosis
and differentiation in acute myeloid leukemia cells. Haematologica
Xia, X. Bioinformatics and drug discovery. Curr. Top. Med. Chem. 2017, 17(15), 1709–1726.
Xiao, J. F.; Zhou, B.; Ressom, H. W. Metabolite identification and quantitation in LC-MS/MS-based
metabolomics. TrAC. 2012, 32, 1–14.
Yamazaki, M.; Mochida, K.; Asano, T .; Nakabayashi, R.; Chiba, M.; Udomson, N.; Yamazaki, Y.; Goodenowe,
D. B.; Sankawa, U.; Y oshida, T .; Toyoda, A.; T otoki, Y .; Sakaki, Y .; Góngora-Castillo, E.; Buell, C. R.; Sakurai,
T.; Saito, K. Coupling deep transcriptome analysis with untargeted metabolic profiling in Ophiorrhiza pumila
to further the understanding of the biosynthesis of the anti-cancer alkaloid camptothecin and anthraquinones.
PCP. 2013, 54(5), 686–696.
. 2018, 103(9), 1472–1483.

234
Yang, Y.; Moore, M. J.; Brockington, S. F.; Soltis, D. E.; Wong, G. K. S.; Carpenter, E. J.; Zhang, Y.; Chen, L.;
Yan, Z.; Xie, Y.; Sage, R. F.; Covshoff, S.; Hibberd, J. M.; Nelson, M. N.; Smith, S. A. Dissecting molecular
evolution in the highly diverse plant clade caryophyllales using transcriptome sequencing. Mol. Biol. Evol.
2015, 32(8), 2001–2014.
Yin, H.; Kassner, M. In vitro high-throughput rnai screening to accelerate the process of target identification
and drug development. Methods Mol. Biol. 2016, 1470, 137–149.
Zhang, F.; Gao, Q.; Khan, G.; Luo, K.; Chen, S. Comparative transcriptome analysis of aboveground and
underground tissues of Rhodiola algida, an important ethno-medicinal herb endemic to the Qinghai-Tibetan
Plateau. Gene. 2014, 553(2), 90–97.
Zhang, H. W.; Lv, C.; Zhang, L. J.; Guo, X.; Shen, Y. W.; Nagle, D. G.; Zhou, Y. D.; Liu, S. H.; Zhang, W.
D.; Luan, X. Application of omics- and multi-omics-based techniques for natural product target discovery.
Biomed. Pharmacother. 2021, 141, 111833.

CHAPTER 11
Natural Products from Endophytic Microorganisms
DAVID C. NWOBODO
1
2
3
1,2,*
and PETER M. EZE
3
*Corresponding author
ABSTRACT
Endophytic microorganisms that live in plant tissues without inflicting harm have been
broadly studied over the past few decades, and their potential for natural product discovery
and development has been widely recognized. The diversity of endophytic microorganisms
and their capacity to synthesize a variety of bioactive molecules make them an attractive
source for both the agricultural and pharmaceutical industries. The isolation, identification,
and characterization of natural products from endophytic microorganisms involve various
techniques, which have been refined over the years to work on the productivity of the
cycle and increase the yield of natural products. Researchers have also used molecular
biology techniques to identify and classify endophytic microorganisms and their natural
products, allowing for more targeted screening of microorganisms for specific compounds
of interest. Continued research in this field is critical to the improvement of new treatment
options for human and animal diseases, as well as sustainable solutions for agricultural
practices. In this chapter, we examine current data on endophytes as a wellspring of novel
and natural bioactive compounds, their diversity, and the various techniques used for the
isolation, identification, and characterization of these microorganisms and their natural
products.
11.1 INTRODUCTION
Plants have for some time been utilized as a wellspring of natural molecules for the
treatment of different diseases and different applications. Unexpectedly, lately, microorganisms related to plants, as opposed to plants themselves, have demonstrated to offer
molecules and compounds with high therapeutic potential (Subbulakshmi et al., 2012).

236
Endophytic microorganisms are a collection of different fungi, bacteria, and actinomycetes that live inside the tissues of plants without inflicting harm (Petrini, 1991). These
microorganisms are ubiquitous in nature and can be found in different plant species,
such as crops, medicinal plants, and trees. Natural products from endophytic microorganisms comprise a vast wellspring of undiscovered bioactive compounds with the
potential to revolutionize the fields of medicine, agriculture, and industry. Throughout
recent many years, endophytic microorganisms definitely stand out because of their
capacity to create a large number of bioactive compounds with possible applications
in agriculture, medicine, and industry (Manganyi and Ateba, 2020). These mixtures
incorporate antimicrobials, anticancer specialists, cancer prevention agents, and other
normal items.
The term endophyte (Gr. endo, inside; phyton, plant) was coined rst by De Bary in
1866 and has become profoundly implanted in literature ever since (Xiang and LiangDong, 2012). De Bary previously presented the expression “epiphyte” for organisms that
live on the outer layer of their host and “endophyte” for those living inside the plant tissue.
Presently, endophytic organisms are dened as microbes that reside inward plant
tissues, comprising various groups of microorganisms (fungi, bacteria, viruses, protozoa)
and even microalgae, and do not cause harmful effects in their host (Vinu et al., 2021).
Initially, the term endophyte was broadly used to include everything from harmful foliar
microbes to mycorrhizal root symbionts (Rezwana, 2007). Although all pathogenic fungi
penetrate the host tissue and exist endophytically, fungi that create apparent symptoms
of disease are excluded from the endophyte category (Caroll, 1986). Nonetheless, a few
mycologists likewise incorporate in the endophyte category fungi that inhabit plant organs
at some stage in their life cycle without inicting obvious harm to their host, as well as
latent internal infections (Petrini, 1986). Therefore, in its most conservative denition, the
term endophyte now includes only organisms that reside within plant tissues at some time
during their life cycle without causing any symptoms.
With recent advances in drug research and development, the bioprospecting of endo-
phytic microbes for useful natural products has become one of the prime focuses. The
study of endophytic microorganisms and their natural products has become a signicant
area of exploration as they offer a promising alternative to synthetic compounds, which
are often associated with toxicity and resistance issues. The objective of this chapter is
to provide an overview of the natural products produced by endophytic microorganisms,
their applications, and future perspectives. The chapter will also discuss techniques for the
isolation and identication of endophytes and the challenges associated with their study.
11.1.1 RATIONAL/WHY ENDOPHYTES?
From time immemorial, man has been troubled by diseases that have inconspicuously
necessitated an effort to maintain good health by man. On the other hand, the emergence
of new diseases, the evolution of disease-causing agents, and what’s more, the enormous
evolvement of general health problems in the total populace have also necessitated an
evolution in man’s approach to tackling these challenges. One such approach to tackling

237
diseases is the use of plants and plant products. The use of plants and herbs in the treatment of disease conditions is as old as man himself. However, not only man has been
placed under the pressure and necessity for survival but plants themselves too have been
placed under such necessity, and evolved naturally to defend themselves. This cycle is
very interesting as it points to a special group of microorganisms, the “endophytes” at the
center. These endophytic microorganisms astonishingly have some innate ability to solve
some crucial plant natural problems and have necessitated their coexistence in a mutual
relationship with the host plant. The mutual relationships between the endophytes and
their hosts are believed to result in survival benefits for both partners (Khare et al., 2018).
Microbial endophytes might protect and enhance the survival of their host plants by the
production of a myriad of biologically active compounds (Strobel, 2018), which can be
harnessed for drug discovery.
Endophytic organisms gained prominence in 1981 after it was discovered that they
could defend their hosts from insects, pests, diseases, and even domestic herbivorous
animals (Webber, 1981). However, according to a report by Stelmasiewicz et al. (2023),
compounds produced by endophytes have gained increasingly signicant attention over
the last 22 years. Due to poverty and the cost of pharmaceutical drugs, people living in
developing countries, and a large number of the world’s population rely on traditional
herbs and plant-based medicines (W.H.O., 2019). However, one will wonder whether the
biological properties or effects derived from these plant-based medicines are produced
by the plants themselves or due to a mutualistic relationship with one or more benecial
microorganisms that reside intercellularly within the plant tissues. In a plant–microbe
relationship, endophytes have attracted much research interest because of their ability
to provide not only novel sources of antimicrobial substances (Nwobodo et al., 2020a)
and cytotoxic compounds, such as anticarcinogenic molecules (Uzma et al., 2018) but
also bio-stimulants for essential oil biosynthesis (El Enshasy et al., 2019; Nwobodo et al.,
2022a). They have also been proven to stimulate plant growth, facilitate the solubility
of nutrients in the plant rhizosphere, and act as biological control agents (Poveda and
Baptista, 2021; Poveda et al., 2020), or enhance plant immunity from biotic stresses (Cui
et al., 2021). Hence, there has been increased interest in endophytic microorganisms as
producers of novel bioactive compounds in recent years.
Second, as the quest for less harmful and more efcient bioactive compounds from
natural sources persists, products originating from plant sources will likely necessitate
enormous-scale harvesting, resulting in the mass destruction of such plants, leading to
climate-related imbalance and ecological disruption (Lawrence and Vandecar, 2015).
Several investigations have led to nding essential plant secondary metabolites (SMs) from
endophytic microbes (Nwobodo et al., 2022a; Bielecka et al., 2022; Ebada et al., 2016),
implying that such organisms could be used as alternate suppliers of these compounds. As
a result, studying plant-associated endophytes may give an alternate method of discovering
novel active metabolites of pharmaceutical importance, while maintaining climatic and
ecological balance.
Until recently, these groups of microorganisms were often neglected as ecosystem
components, which is the reason they are currently viewed as a treasure mine of untapped
biodiversity (Nicoletti and Fiorentino, 2015). Several investigations have documented a

238
vast number of bioactive chemicals isolated from endophytes, including phenols, quinines,
alkaloids, avonoids, peptides, terpenoids, and steroids (Manganyi and Ateba, 2020).
Almost all plant species have one or more endophytic organisms, but only a few are studied
for their endophytic biodiversity and capacity to synthesize bioactive SMs (Strobel, 2018).
Endophytes are thought to be more metabolically active than their free-living counterparts
because of their distinct activities in nature and activation of multiple pathways of metabolism for survival in host tissues (Fadiji and Babalola, 2020).
11.2 DIVERSITY OF ENDOPHYTIC MICROORGANISMS
Endophytes are currently regarded as an excellent source of bioactive natural products due
to the fact that many of them occupy millions of peculiar biological niches and develop in
a variety of strange conditions (Nwobodo et al., 2020b). Endophytes are microbes that are
found in a wide variety of plants, from tropical rainforests to dry deserts and are highly
diverse. Although it is believed that a single host may contain up to a million species of
endophytes, only a few of these have been identified so far (Gakuubi et al., 2021). This
suggests that there is a potential to discover new natural products from the multitude of
endophytes inhabiting different plants in various ecosystems. The diversity of endophytes
is influenced by a few factors, for example, the host plant particularity , geological area, and
environmental conditions. Endophytes exhibit host specificity, which means that they are
only found in certain plant species or families (Kim et al., 2013).
Geographic location also greatly contributes to the diversity of endophytic microorganisms. Different regions of the world have unique plant species that harbor diverse
endophytic microorganisms. Temperature, pH, and nutrition availability are all environ-
mental factors that inuence the variety of endophytic microorganisms (Ali et al., 2021).
Endophytic microorganisms living in plants growing in extreme environments, such as
deserts or thermal springs, are metabolically adapted to survive under such harsh conditions (Kochhar et al., 2022). It has also been demonstrated that the diversity of endophytes
in the tropical and subtropical regions is substantially greater than in other parts of the
world (Meshram and Gupta, 2019). Additionally, variations in seasons and weather have
also been identied as a major driver of the distribution and variety of fungal endophytes
(Materatski et al., 2019). The most common types of endophytes are bacteria, actinomycetes, and fungi (Gouda et al., 2016).
11.2.1 ENDOPHYTIC BACTERIA AND ENDOPHYTIC ACTINOMYCETES
The endophytic environment provides protection to bacteria that can survive within plants.
Recent reports have shown that endophytic bacteria and actinomycetes are highly diverse
and play significant roles in plant growth, stress tolerance, and the synthesis of natural
products with potential applications in biotechnology and medicine (T shikhudo et al., 2023;
Paul and Pratim, 2022). The composition and diversity of endophytic bacteria isolated
from various regions of the same plant may differ (Afzal et al., 2019). The rhizosphere

239
is the most prevalent route for bacterial endophytes to colonize their hosts. The most
common phyla of bacterial endophytes are Proteobacteria, Firmicutes, and Actinobacteria,
with the most common genera being Bacillus, Pseudomonas, Burkholderia, Micrococcus,
Stenotrophomonas, Microbacterium, and Pantoea being the most frequently occurring
genera (Burragoni and Jeon, 2021). Endophytic actinobacteria are the most prevalent type
of bacterial endophytes in practical applications as they are most abundant in roots, followed
by stems, and least abundant in leaves (Ganapathy and Natesan, 2018). The most prevalent
endophytic actinobacterial genera are Streptomyces, Microbacterium, Mycobacterium,
Arthrobacter, and Curtobacterium (Hardoim et al., 2015). Generally, bacterial endophytes
are highly diverse in nature and are reported to synthesize a large variety of useful bioactive
metabolites, with over 76% of these compounds identified specifically from the genus
Streptomyces (Gouda et al., 2016). Mangrove endophytes are extremely diverse, and
according to Azman et al. (2015), it is assumed that mangrove ecosystems are excellent
breeders of novel actinobacterial species.
Endophytic actinomycetes are lamentous bacteria that have been shown to synthesize a large variety of bioactive compounds, including antibiotics, antitumor agents, and
enzymes (Barka et al., 2016). Endophytic actinomycetes are known to possess a larger
genome than endophytic bacteria, with many genes encoding for SM biosynthesis (Azman
et al., 2015). This difference in genome size and metabolic capacity may contribute to the
ability of endophytic actinomycetes to synthesize a wider group of natural products than
endophytic bacteria.
Recent developments in techniques for high-throughput sequencing have made
it possible to identify novel endophytic bacteria and actinomycetes from various plant
species and environments. These technologies have also facilitated the understanding of
the functional roles of these endophytic microbes in the plant–microbe relationship leading
to the synthesis of useful natural products.
11.2.2 ENDOPHYTIC FUNGI
Endophytic fungi are one of the most diversified populations of endophytic microorganisms,
with an estimation of over 1 million species (Sagita et al., 2021). The abundance and variety
of fungal endophytes in numerous plants have been reported, with respect to different
environmental factors such as drought, pH, temperature, salinity, and other extreme
conditions in extreme environments (Rigobelo and Baron, 2021). The majority of endophytic
fungi are Ascomycetes, Deuteromycetes, and Basidiomycetes (Gakuubi et al., 2021). Based
on characteristics such as taxonomy, host range, transmission, and plant fitness benefits,
fungal endophytes are divided into two groups: clavicipitaceous and nonclavicipitaceous
(Rodriguez et al., 2009). Clavicipitaceous fungi are phylogenetically linked and are
transmitted vertically by seeds, whereas nonclavicipitaceous endophytes, which are
predominantly Ascomycota, are polyphyletic and found in a variety of plant species. Many
of these endophytic fungi can live in both endophytic and free-living environments. The
amount of SMs produced by fungal endophytes has been found to be greater than that of any
other endophytic microbe (Zhang et al., 2006).

240
Fungi have been widely studied as a source of bioactive substances. Alexander Fleming’s
1928 discovery of penicillin from Penicillium notatum was the rst milestone in this eld
(Fleming, 1945). Other organisms’ selection pressure on fungal growth, such as predators,
competitors, and viruses, causes the synthesis of metabolites by fungi to defend their growth.
However, these metabolites frequently have additional bioactivities. Endophytic fungi
colonization of host plants is thought to contribute to host plant adaptation to biotic and
abiotic stress factors, which has been linked to fungal natural product synthesis (Zhang et al.,
2006). Endophytic fungi have a variety of effects on their host plants and their survival
and are normal to exert these effects via varied pathways or methods. One such method is
via the production of SMs. Fungal endophytes are recognized as one of the most inventive
producers of SMs that play signicant biological roles and are potential sources of innovative natural products (Selim et al., 2012). Some endophytic fungi isolated from plants by
several researchers include members of the genera Fusarium, Acremonium, Cladosporium,
Aspergillus, Penicillium, Curvularia, Stemphylium, Pseudofusicoccum, and Piriformospora
(Eze et al., 2019; Abba et al., 2018; Abonyi et al., 2018; Wang et al., 2018; Karunai and
Balagengatharathilagam, 2014), among others.
11.3 METHODS FOR ISOLATION AND IDENTIFICATION OF ENDOPHYTIC
MICROORGANISMS
The isolation and identification of endophytic microorganisms can be challenging, as
these microorganisms live within the plant tissues and are often present in low numbers.
Nonetheless, it is a crucial step in understanding their potential roles in plant–microbe
interactions and in exploring their potential applications. Plant endophytic microbe isolation
and characterization require several methods that aim to eliminate surface contaminants
while preserving the microorganisms within the plant tissues. In this section, we will
describe the most common methods used for the isolation and identification of endophytic
microorganisms.
11.3.1 ISOLATION METHODS
There are several methods that have been used for the isolation of endophytic microorganisms. The major methods include the following.
Culture-dependent methods involve the use of different media for the isolation and cultivation of endophytic microorganisms, based on the principle that different microbial species
have diverse nutritional and environmental requirements for growth. Examples of media
used in these methods include potato dextrose agar (PDA), nutrient agar (NA), and tryptic
soy agar (TSA). This method involves the following.

241
11.3.1.1.1 Dilution Plating
This method involves the dilution of plant tissue extracts in a suitable nutrient-rich growth
medium, followed by the plating of the dilutions on agar plates (Singh et al., 2022). The
method allows for the isolation of individual colonies from the diluted plant tissue homogenates. Endophytic microorganisms have been isolated from diverse plant tissues including
stems, leaves, and roots using the dilution plating technique.
11.3.1.1.2 Direct Plating
This method involves the direct plating of plant tissue sections on agar plates (Singh et al.,
2022). The method eliminates the need for homogenization and dilution of plant tissues, but
it is less commonly used due to the difficulty in obtaining uniform sections of plant tissues.
Direct plating has been shown to be effective in isolating endophytic microorganisms from
the roots and stems of various plant species.
Despite their usefulness in isolating endophytic microorganisms, culture-dependent
methods have limitations, such as the underrepresentation of microbial diversity due to the
inability of some microorganisms to grow under laboratory conditions.
Culture-independent methods, on the other hand, are based on the extraction and amplification of microbial DNA from plant tissue, followed by the sequencing and analysis of the
DNA without the need for cultivation. These methods are more comprehensive in revealing
the microbial diversity present in the plant tissue (Hardoim et al., 2015). Polymerase chain
reaction (PCR), denaturing gradient gel electrophoresis (DGGE), and terminal restriction
fragment length polymorphism (T-RFLP) are examples of culture-independent technologies.
Culture-independent methods also have limitations such as the risk of DNA sample contamination and the difficulty in interpreting the results.
11.3.2 IDENTIFICATION METHODS
Once the endophytic microorganisms have been isolated, various methods can be used to
identify them, which include the following.
One of the most common methods is the morphological or phenotypic identification
method, which involves the characterization of endophytic microorganisms based on their
observable characteristics, such as colony morphology, pigmentation, and growth rate
on different growth media (Ambikapathy et al., 2023). This is a traditional method of

242
identifying microorganisms but has limitations as many endophytic microorganisms have
similar characteristics.
The application of molecular techniques for the characterization of endophytic microorganisms is increasingly being adopted. These techniques involve the sequencing of conserved
genes such as the 16S rRNA gene for bacteria (Tiwari and Bae, 2022) and the internal
transcribed spacer (ITS) region for fungi (Nwobodo et al., 2022a) to identify the microorganisms at the species or genus level. Examples of molecular identification techniques for
endophytic microorganisms include PCR and DNA sequencing. PCR amplifies specific
regions of microbial DNA, allowing for the identification of specific microbial groups.
DNA sequencing provides more accurate identification of microbial species based on the
comparison of DNA sequences with reference sequences in databases. Molecular identification has been shown to be a reliable and accurate method for identifying endophytic
microorganisms.
It is vital to note that the method of isolation and identication chosen is dependent on
a number of criteria, such as the type of microorganism being studied, the availability of
resources, and the research objectives. The combination of different methods can provide a
deeper comprehension of the diversity and features of endophytic microorganisms.
11.4 BIOACTIVE COMPOUNDS FROM ENDOPHYTIC MICROORGANISMS
Endophytic microorganisms including fungi and bacteria have been discovered to be
producers of potential bioactive agents with diverse applications. Particularly, endophytic
microorganisms, mostly fungi, have gained popularity as a source of pharmacological
metabolites with various therapeutic uses. In recent years, there has been an upsurge in the
production and commercialization of these metabolites from endophytes. Tiwari and Bae
(2022) have reported several such metabolites, and Figure 11.1 provides a few selected
examples. Based on their activity , these compounds can be categorized into several categories including antibiotics, anticancer, antiviral, antifungal agents, and antioxidants.
11.4.1 ANTIBIOTICS
Endophytic microorganisms are a promising source of antibiotics, which are important for
treating bacterial infections. The production of antibiotics by endophytes is believed to be
a mechanism of competition with other microorganisms in the host plant. The polyketide
citrinin produced by the endophytic fungus Penicillium janthinellum isolated from Melia
azedarach fruits displayed 100% antibacterial action against Leishmania
sp. (Marinho et al.,
2005). Liu et al. (2008) found a bioactive substance called 7-amino-4-methyl coumarin in the
culture extracts of the endophytic fungus Xylaria sp. YX-28 obtained from Ginkgo biloba L.
Соседние файлы в папке Библиотека им академика М.И. Перельмана
